Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002010135-25-000004
Filing Date
2025-10-22
Accepted
2025-10-22 21:05:08
Documents
1
Period of Report
2025-10-21

Document Format Files

Seq Description Document Type Size
1 form4-10222025_091005.html 4  
1 form4-10222025_091005.xml 4 3604
  Complete submission text file 0002010135-25-000004.txt   5086
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O NATERA, INC. 13011 MCCALLEN PASS, BLDG A, SUITE 100 AUSTIN TX 78753
Business Address
Fesko John (Reporting) CIK: 0002010135 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37478 | Film No.: 251411216